Cargando…

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer

Cytotoxic chemotherapy agents (e.g., cisplatin) are the first-line drugs to treat non-small cell lung cancer (NSCLC) but NSCLC develops resistance to the agent, limiting therapeutic efficacy. Despite many approaches to identifying the underlying mechanism for cisplatin resistance, there remains a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Lu, Lan, Xiaoying, Shi, Xianping, Zhao, Kai, Wang, Dongrui, Wang, Xuejun, Li, Faqian, Huang, Hongbiao, Liu, Jinbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520727/ https://www.ncbi.nlm.nih.gov/pubmed/28518145 http://dx.doi.org/10.1038/cddis.2017.210

Ejemplares similares

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016)

Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation
por: Lan, Xiaoying, et al.
Publicado: (2017)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
por: Lan, Xiaoying, et al.
Publicado: (2016)

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment
por: Jiang, Lili, et al.
Publicado: (2016)

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition
por: Shi, Xianping, et al.
Publicado: (2015)

Hepatic Deficiency of COP9 Signalosome Subunit 8 Induces Ubiquitin-Proteasome System Impairment and Bim-Mediated Apoptosis in Murine Livers
por: Lei, Daoxiong, et al.
Publicado: (2013)

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
por: Chen, Xin, et al.
Publicado: (2014)

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
por: Huang, Hongbiao, et al.
Publicado: (2015)

Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells
por: Zhang, Jinyu, et al.
Publicado: (2020)

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
por: Zhao, Chong, et al.
Publicado: (2017)

Rap1 and Rap2 Antagonistically Control Endothelial Barrier Resistance
por: Pannekoek, Willem-Jan, et al.
Publicado: (2013)

Bilirubin neurotoxicity is associated with proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
por: Yang, Zhengyuan, et al.
Publicado: (2021)

The Small Gtpase, Rap1, Mediates Cd31-Induced Integrin Adhesion
por: Reedquist, Kris A., et al.
Publicado: (2000)

An alternative splice isoform of mouse CDK5RAP2 induced cytoplasmic microtubule nucleation
por: Nakamura, Akari, et al.
Publicado: (2022)

Ubiquitin Carboxyl-Terminal Hydrolase L1 of Cardiomyocytes Promotes Macroautophagy and Proteostasis and Protects Against Post-myocardial Infarction Cardiac Remodeling and Heart Failure
por: Wu, Penglong, et al.
Publicado: (2022)

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798
por: Yang, Xuemei, et al.
Publicado: (2017)

Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
por: Pan, Chun-Hao, et al.
Publicado: (2016)

TRIB2 contributes to cisplatin resistance in small cell lung cancer
por: Liang, Yuanxin, et al.
Publicado: (2017)

Stress-mediated dysregulation of the Rap1 small GTPase impairs hippocampal structure and function
por: Bjornson, Kathryn J., et al.
Publicado: (2023)

RAP2 Mediates Mechano-responses of Hippo Pathway
por: Meng, Zhipeng, et al.
Publicado: (2018)

SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
por: Cui, Fei, et al.
Publicado: (2020)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
por: Wu, Longqiu, et al.
Publicado: (2022)

Association between EGFR mutation and expression of BRCA1 and RAP80 in non-small cell lung cancer
por: Sun, Xia, et al.
Publicado: (2018)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017)

Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells
por: Wu, Hui-Mei, et al.
Publicado: (2015)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
por: Jiang, Liling, et al.
Publicado: (2019)

Cytoplasm-localized SIRT1 downregulation attenuates apoptosis and cell cycle arrest in cisplatin-resistant lung cancer A549 cells
por: Yu, Hyeran, et al.
Publicado: (2020)

CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
por: Wang, Yan, et al.
Publicado: (2018)

Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells
por: Wu, Wei, et al.
Publicado: (2010)

Lung‐specific exosomes for co‐delivery of CD47 blockade and cisplatin for the treatment of non–small cell lung cancer
por: Cui, Zhilei, et al.
Publicado: (2022)

Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer
por: Shi, Liang, et al.
Publicado: (2018)

Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance
por: Wang, Meng-Ran, et al.
Publicado: (2020)

Rap1b but not Rap1a in the forebrain is required for learned fear
por: Chen, Wen-Bing, et al.
Publicado: (2020)

COrona-rap
por: van Hogendorp, Sophie
Publicado: (2020)

Rapping Mania
Publicado: (1853)

Cannot write session to /tmp/vufind_sessions/sess_t30ca4t31dpbb75rp5s5qh66gl